QB3 coordinates several activities with Pfizer to strengthen the research collaborations between our institutions. These include an active program for sponsored research agreements, material transfers and scientist exchange.
QB3 Innolab coordinates the submission of ideas to Pfizer by QB3 campus faculty members. Investigators who believe they have projects that would be of interest to Pfizer should contact Neena Kadaba at firstname.lastname@example.org.
Pfizer’s therapeutic areas of interest include: inflammation, immunology, diabetes, obesity, neuroscience and oncology. However, novel technologies and basic biology projects are also frequently funded.
Over 25 collaborative projects have been initiated since the alliance was formed in 2008. The projects vary in scope and funding, and the timeframes range from one to three years. Funded projects span the diverse interests of Pfizer and the University of California, represent the broad shared research interests between faculty at UC and Pfizer scientists, working towards the goal of developing a strong program of scientific collaboration between our institutions.
A master agreement has been signed to enable access to Pfizer compounds. Investigators that have a project that would benefit from incorporating compounds from Pfizer should contact us at email@example.com.